Work

Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447

Year: 2026

Type: erratum

Abstract: In the original article [...].

Source: Pharmaceutics

DOI: 10.3390/pharmaceutics18070808

Authors: Changpeng Cui, Qingji Huo, Xue Xiong, Kexin Li, Melissa L. Fishel, Baiyan Li, Hiroki Yokota

Institutions: Harbin Medical University, Indiana University – Purdue University Indianapolis, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine

Language: English

Topic: Antimicrobial Peptides and Activities

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,499

Funders: National Natural Science Foundation of China, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: G1075482105, G1208790434, G1229365714, G1747559470, G2051703870, Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinations, Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis, Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors, G414764223, G4210260303, A Fragment-Based Strategy for K-RAS Covalent Inhibitors, G6146444198, G6339156551, Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment, G7312681303, G7724476976, Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer, G7873504547, G79252004, G8083819122, G8352017330, G8361772177, G8746925924, Indiana University Melvin and Bren Simon Cancer Center Support Grant

OpenAlex ID: W7166644019

Cites: 1

Cited by:

Related to: